Trial intelligence / Profile preview

10-Day Concomitant vs 14-Day Hybrid for H. Pylori Eradication

NCT03592069Phase 4Completed

Sponsor
Alexandra Hospital
Start
Feb 2018
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of esomeprazole, amoxicillin, clarithromycin, metronidazole in Helicobacter pylori infection, sponsored by Alexandra Hospital. Started Feb 2018; status: completed.

02

Drugs

esomeprazoleamoxicillinclarithromycinmetronidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT03592069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03592069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call